Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:BJDX

Bluejay Diagnostics - BJDX Stock Forecast, Price & News

$0.75
+0.01 (+1.90%)
(As of 11/25/2022 08:57 PM ET)
Add
Compare
Today's Range
$0.63
$0.75
50-Day Range
$0.63
$0.89
52-Week Range
$0.61
$3.59
Volume
26,600 shs
Average Volume
545,220 shs
Market Capitalization
$15.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

Bluejay Diagnostics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,233.7% Upside
$10.00 Price Target
Short Interest
Healthy
1.54% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.29) to ($0.05) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.53 out of 5 stars

Medical Sector

138th out of 1,044 stocks

Surgical & Medical Instruments Industry

14th out of 104 stocks

BJDX stock logo

About Bluejay Diagnostics (NASDAQ:BJDX) Stock

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Receive BJDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

BJDX Stock News Headlines

Investing in Blue Chip Stocks
4 Stocks Under $2 Insiders Are Aggressively Buying
Bluejay Diagnostics GAAP EPS of -$0.09
Bluejay Diagnostics Inc (BJDX)
See More Headlines
Receive BJDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

BJDX Company Calendar

Today
11/27/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/09/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BJDX
Fax
N/A
Employees
9
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+1,233.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-3,490,000.00
Pretax Margin
-3,361.77%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.69 per share

Miscellaneous

Free Float
11,023,000
Market Cap
$15.11 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Indranil Dey (Age 58)
    Pres, CEO & Director
    Comp: $181.61k
  • Dr. Jason Cook (Age 40)
    Chief Technology Officer
    Comp: $308.3k
  • Mr. Kenneth R. Fisher CPA (Age 42)
    Chief Financial Officer
  • Mr. Edwin Rule
    VP of Regulatory, Quality & Compliance
  • Mr. Kevin Vance (Age 65)
    Chief Commercial Officer
  • Mark W. Feinberg
    Chief Medical Advisor
  • Dr. Mark W. Feinberg M.D.
    Chief Medical Advisor













BJDX Stock - Frequently Asked Questions

Should I buy or sell Bluejay Diagnostics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bluejay Diagnostics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BJDX shares.
View BJDX analyst ratings
or view top-rated stocks.

What is Bluejay Diagnostics' stock price forecast for 2023?

1 Wall Street analysts have issued 12-month target prices for Bluejay Diagnostics' stock. Their BJDX share price forecasts range from $10.00 to $10.00. On average, they predict the company's share price to reach $10.00 in the next year. This suggests a possible upside of 1,233.7% from the stock's current price.
View analysts price targets for BJDX
or view top-rated stocks among Wall Street analysts.

How have BJDX shares performed in 2022?

Bluejay Diagnostics' stock was trading at $2.56 at the beginning of the year. Since then, BJDX shares have decreased by 70.7% and is now trading at $0.7498.
View the best growth stocks for 2022 here
.

When is Bluejay Diagnostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our BJDX earnings forecast
.

When did Bluejay Diagnostics IPO?

(BJDX) raised $22 million in an IPO on Wednesday, November 10th 2021. The company issued 2,160,000 shares at a price of $10.00 per share.

What is Bluejay Diagnostics' stock symbol?

Bluejay Diagnostics trades on the NASDAQ under the ticker symbol "BJDX."

How do I buy shares of Bluejay Diagnostics?

Shares of BJDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bluejay Diagnostics' stock price today?

One share of BJDX stock can currently be purchased for approximately $0.75.

How much money does Bluejay Diagnostics make?

Bluejay Diagnostics (NASDAQ:BJDX) has a market capitalization of $15.11 million. The company earns $-3,490,000.00 in net income (profit) each year or ($0.44) on an earnings per share basis.

How can I contact Bluejay Diagnostics?

The official website for the company is www.bluejaydx.com. The company can be reached via phone at 978-631-0152 or via email at ir@bluejaydx.com.

This page (NASDAQ:BJDX) was last updated on 11/28/2022 by MarketBeat.com Staff